Mixing Migraine Meds and Antidepressants Can Be Dangerous
People taking migraine drugs together with some antidepressants are at risk of a life-threatening condition, according to a new FDA advisory.
The problem arises when people take migraine headache drugs called triptans with antidepressants known as selective serotonin/norepinephrine reuptake inhibitors (SSRIs/SNRIs).
The combination can cause seritonin syndrome. The syndrome occurs when the body has too much of the nervous system chemical serotonin.
People taking both drugs classes can experience restlessness, hallucinations, loss of coordination, fast heart beat, rapid changes in blood pressure, increased body temperature, overactive reflexes, nausea, vomiting and diarrhea.
Commonly prescribed SSRIs include Prozac, Zoloft, Paxil and Lexapro. SNRIs include Cymbalta and Effexor. Triptans include Amerge, Axert, Imitrex and Zomig.
The FDA has asked the manufacturers of all three types of drugs to update their prescribing information to warn of the potential risk of serotonin syndrome.
Patients should talk to a doctor before stopping either medication, the FDA said.
FDA health advisory.
Discover Alternative approaches to depression.
The problem arises when people take migraine headache drugs called triptans with antidepressants known as selective serotonin/norepinephrine reuptake inhibitors (SSRIs/SNRIs).
The combination can cause seritonin syndrome. The syndrome occurs when the body has too much of the nervous system chemical serotonin.
People taking both drugs classes can experience restlessness, hallucinations, loss of coordination, fast heart beat, rapid changes in blood pressure, increased body temperature, overactive reflexes, nausea, vomiting and diarrhea.
Commonly prescribed SSRIs include Prozac, Zoloft, Paxil and Lexapro. SNRIs include Cymbalta and Effexor. Triptans include Amerge, Axert, Imitrex and Zomig.
The FDA has asked the manufacturers of all three types of drugs to update their prescribing information to warn of the potential risk of serotonin syndrome.
Patients should talk to a doctor before stopping either medication, the FDA said.
FDA health advisory.
Discover Alternative approaches to depression.

0 Comments:
Post a Comment
<< Home